Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Temple University Jazz Band Records “COVID SESSIONS” During Quarantine Using New Technology, Bedrooms, Basements as Mini Studios Then Recording One Lone Player at a Time


“Recording this album was important for all of us, It was a remarkable experience from a technology and a music perspective. I am so proud of what was accomplished as the first-of-its kind new way to record in a pandemic.” Dr. Robert Stroker, Vice Provost and Dean, Temple University, Boyer College

The Temple University Jazz Band started the year off with a bang as they won first place at the inaugural Jack Rudin Jazz Championship at Jazz at Lincoln Center. Their calendar was filling up with performances and time in the studio to record an album of the material that had earned them their latest crown. Any plans were quickly upended when the COVID pandemic hit and quarantining was mandated. Feeling more disconnected and isolated each passing day, educators and students were determined to not let the pandemic prevent them from creating art. They just needed to figure out how they were going to record a Large Jazz Ensemble Album when no two people could ever be in the same room. And so that is what they did:

  • Engineer/Producer and Associate Professor of Music Technology David Pasbrig reached out to his colleague GRAMMY- and Emmy-winning sound engineer John Harris (Engineer, Non-Classical) who he knew had been working on new technology to record music remotely.
  • They used Harris’ technology and fine-tuned it specifically for their challenging situation and developed four mobile units that were mini recording studios for students
  • They sent boxes to students, trained students, no guarantees as to when they would be delivered.
  • Two engineers, along with Director Terell Stafford, started recording each musician’s individual parts for the entire album in whatever space they had declared the studio.
  • CHALLENGES: WiFi not good enough so ethernet cables had to be used….one student with no ethernet turned to a local church to set up mini studio. MORE CHALLENGES: Vaulted Ceilings, echoes, nat sound, stuffy closets, a ceiling fan.
  • Mixing and mastering took 3x the amount of time it would have taken if recorded together in studio
  • Something was wrong with final mix; they realized the base player had a ceiling fan going during recording session – back to the drawing board (sans fan).
  • 7 days to mix, master, create album artwork, liner notes, etc.


“I watched as each student became hyper aware of the intricacies and importance of each performer, which elevated their own performance. Although isolated as individual recordings, the members talked more and became closer as they helped each other figure out this new way of making music. A real testament to the power of music and the fortitude and resilience of young music makers.” Terell Stafford, Director

“Recording this album was important for all of us. It was a remarkable experience from a technology and music perspective. It was an honor, and I am so proud of what was accomplished as the first-of-its kind new way to record in a pandemic.” Dr. Robert Stroker, Vice Provost and Dean, Temple University Boyer College of Music and Dance, Founder/Exec Producer, BCM&D Records

Listen: https://tujb.hearnow.com/

Share article on social media or email:

GIFTED Healthcare Named New Orleans’ Best Place to Work in 2020


Our team’s culture is a blend of innovation, grit, and integrity and is built on the foundation of our values, which have propelled our growth over the years.

National travel nurse agency GIFTED Healthcare is thrilled to announce that it has been named a “Best Place to Work” by New Orleans CityBusiness, a highly-regarded business publication in the New Orleans area. Created in 2003, CityBusiness’ “Best Places to Work” list recognizes the city’s 50 top employers, honoring 35 large companies and 15 small. GIFTED Healthcare is listed in the Large category.

To participate in “Best Places to Work,” companies must disclose workforce data such as salaries, benefits, retention levels and employee advancement. Honorees are chosen based on questionnaires that explore offered employee benefits, including average salary, health care, paid time off and employee programs. In addition, quality of workplace culture is measured with an anonymous survey of company employees.

All CityBusiness “Best Places to Work” will be honored at an upcoming virtual awards event at noon on Friday, December 4th. The top three large and small companies will be selected and announced during the event.

Regarding this exciting honor, GIFTED CEO P.K. Scheerle, RN, said, “Our mission is to create a shared sense of purpose in serving our clients and nurses. GIFTED Healthcare is a great place to work because we hire the most exceptional people. Our team’s culture is a blend of innovation, grit, and integrity and is built on the foundation of our values, which have propelled our growth over the years. We hold these values in mind every time we engage with a client or clinician, and we look forward to growing and strengthening these partnerships even more in the future.”

GIFTED Healthcare looks forward to continued growth and success. GIFTED extends thanks to all of its incredible nurses, clients, and teammates for their priceless contributions to the company’s workplace culture and creative staffing solutions.

About GIFTED Healthcare: Headquartered in New Orleans since 2006, GIFTED Healthcare is a nurse owned and operated company that provides creative workforce solutions for healthcare clients and outstanding career opportunities to clinicians. GIFTED’s offices can be found in Louisiana, Texas, Oklahoma, and Arkansas. Its range of service lines includes Travel, Per Diem, LTAC, Infusion, and Government contracts. Most importantly, GIFTED is dedicated to providing excellent service and support for nurses and clients so that they can thrive.

Share article on social media or email:

Catalent Launches OneXpress™ Solution to Accelerate Oral Dosage Products from Clinic to Launch


The oral drug development path is lengthy and complex, so to maximize speed and flexibility and reduce costs, innovators need to select development partners with the expertise and capabilities that are best suited for each stage in their development cycle.

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the launch of its new OneXpress™ service for the integrated development, scale up and manufacturing of new oral solid dosage forms.

The OneXpress solution accelerates a program’s transition from early-phase development to commercial-ready manufacturing by leveraging Catalent’s phase-appropriate scale, technologies, extensive oral dose form network and expertise to reduce risk, complexity and cost between phases. By eliminating the need to transition projects between multiple service providers, duplication of tasks can be avoided, API consumption can be reduced, and drug products can reach patients faster.

With a tightly integrated global network and streamlined program management, the OneXpress solution combines the expertise at Catalent’s early-phase drug development centers in Nottingham, U.K., Somerset, New Jersey, and San Diego in the U.S. with the proven track-record of Catalent’s oral solid commercial manufacturing facilities.

“The oral drug development path is lengthy and complex, so to maximize speed and flexibility and reduce costs, innovators need to select development partners with the expertise and capabilities that are best suited for each stage in their development cycle,” commented Jeremie Trochu, Vice President, Oral and Specialty Delivery at Catalent. “Our teams have collaborated across sites to harmonize equipment, materials and protocols, to ensure accelerated and seamless scale up from first-in-human trials to commercial launch. We successfully transferred over a dozen OneXpress projects in the last year alone.”

The OneXpress solution adds to Catalent’s range of integrated offerings, including OneBio™ Suite, OptiForm® Solution Suite, and OptiForm Total Supply, which can accelerate the development and scale up of promising compounds into successful treatments.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

“Go Pescatarian” this October for First Annual Pescatarian Month


To inaugurate the holiday, Dish on Fish is inviting seafood lovers everywhere to “Go Pescatarian.”

The first annual National Pescatarian Month kicks off this October, and you’re invited! Get a jumpstart on a healthy new lifestyle and take part in the first-ever National Pescatarian Month this October!

National Pescatarian Month is a worldwide celebration of the pescatarian diet, which features a combination of seafood and vegetarian options. Those vegetarian choices might include grains, nuts, seeds, legumes, fruits, vegetables, eggs, and dairy items. The variety of seafood options, of course, is as vast as the ocean itself.

But who gets to just name a month, anyway? Not just anybody—the folks at National Today, arbiters of special days and months on the calendar and the experts in tracking food culture, designated October as National Pescatarian Month starting this year.

To inaugurate the holiday, Dish on Fish is inviting seafood lovers everywhere to “Go Pescatarian.” Throughout the month, the blog is providing its visitors ample opportunities to get acquainted with the lifestyle, showcasing nutritious, pescatarian-focused meal plans and sharing tips for simple seafood prep and cooking that even kitchen novices can tackle.

In addition, Dish on Fish has created a new, pescatarian-friendly e-cookbook, “Everyday Seafood Recipes: 53 Quick & Easy Dishes,” featuring primarily pescatarian, original recipes for the home cook.

“Our new e-cookbook shows just how easy it is to include seafood in your family’s meal plans,” explains Judy Dashiell, the senior vice president of the National Fisheries Institute. “Many of the book’s recipes utilize everyday pantry staples and we illustrate a lot of different techniques for preparing seafood—we even have pescatarian recipes for the slow cooker and air fryer!”

Nearly all of the book’s recipes—for breakfast, lunch, dinner, and snacks—have been created or approved by nationally recognized registered dietician Rima Kleiner, MS, RDN.

Experts say going pescatarian can augment one’s intake of vital nutrients—including healthy proteins and omega-3 fatty acids—and help improve brain and heart health, protect against diabetes, and reduce the risk of inflammation. And the federal Dietary Guidelines for Americans recommends the consumption of seafood at least two or three times a week.

To learn more about National Pescatarian Month, visit dishonfish.com or head to the blog’s Facebook, Pinterest, Twitter and Instagram pages.

###

About National Pescatarian Month

National Pescatarian Month is recognized each October in celebration of pescatarians and the pescatarian diet. This officially designated holiday embraces the health and lifestyle advantages of choosing a pescatarian diet, which consists of seafood + vegetarian options. The holiday encourages consumers to “Go Pescatarian” in October, with a goal of eating a least two to three seafood meals a week, whether enjoyed at a restaurant or prepared at home. National Pescatarian Month is sponsored by the National Fisheries Institute (NFI), a nonprofit organization dedicated to educating the public about seafood safety, sustainability and nutrition. To learn more about National Pescatarian Month, visit the NFI’s blog Dish on Fish.

About The National Fisheries Institute

The National Fisheries Institute is a nonprofit organization dedicated to education about seafood safety, sustainability and nutrition. From seagoing vessels to favorite seafood restaurants, The NFI’s diverse member companies bring delicious fish and shellfish to American families. The NFI promotes the federal government’s Dietary Guidelines, which suggests Americans include fish and shellfish in their diets at least twice per week, for longer, healthier lives.

The NFI and its members are committed to sustainable management of our oceans and to being stewards of our environment, through the institute’s embrace of the United Nations’ Principles for Responsible Fisheries. The NFI believes the investment it makes in the world’s oceans today will provide our children and future generations the health benefits of a plentiful supply of fish and other seafood tomorrow.

From responsible aquaculture and a marketplace supporting free trade to ensuring consumers and the media have the facts about the health benefits of fish and shellfish, The NFI and its members support and promote sound public policy based on ground-truth science.

Share article on social media or email:

Wearsafe Labs Announces the Givesafe Program Inspired Giving Fueled by Safety, Security and Support


News Image

With relationship abuse, there is no one-size-fits-all-solution — but for some survivors, Wearsafe can be a great source of protection and peace of mind,” says Katie Ray-Jones, CEO of the National Domestic Violence Hotline.

Wearsafe Labs, creators of personal safety and emergency communication products via IoT and mobile devices, is proud to announce that as a result of the COVID-19 pandemic, they are expanding their Givesafe Program to support nonprofits. In addition to donating 20% of sales to partner organizations, Wearsafe will offer donors the ability to double their impact when they designate their contribution to an organization for the purchase of Wearsafe Tags. Wearsafe will then match the designated gift with an in-kind donation of Wearsafe Tags in the same amount. Wearsafe is also working with nonprofits to provide products to its community members who need them most- at a discounted price.

“After my parents experienced a horrible fire in their home, couldn’t reach me, and I didn’t find out about it until hours later. I had to find a way for them to call for help without using their phone,” says David Benoit, co-founder, and CEO of Wearsafe. “Today, when a person presses the Wearsafe Tag, a preselected group of contacts is sent an alert via text and an email containing live audio and exact GPS location, so that the right help can be coordinated, right away. With so many people isolated due to COVID, calling for help is even more difficult. Our Givesafe Program provides multiple paths to get Wearsafe into the hands of people who need it most and help organizations raise funds critical to achieving their missions. The Givesafe Program has strategic partnerships with the National Domestic Violence Hotline, amfAR, the Ali Forney Center, and End Allergies Together,” adds Benoit.

“When survivors reach out to our advocates, they are looking for support, validation, safety planning, and connection to local resources. By informing our contacts of Wearsafe’s platform and the nondescript Wearsafe Tag, we can provide another option for survivors to access immediate support and safety, without having to say a word,” says Katie Ray-Jones, CEO of the National Domestic Violence Hotline. “With relationship abuse, there is no one-size-fits-all-solution — but for some survivors, Wearsafe can be a great source of protection and peace of mind.”

“The in-kind matching component of the Givesafe Program is a game-changer for any organization, especially those with limited funding but, who have the pressing need to help the population they serve to stay connected and safe,” says Alexander Roque, President and Executive Director of the Ali Forney Center. “We are so grateful for financial support from donors, and with Wearsafe’s in-kind match, we can double the impact of a donor gift and can provide Wearsafe to even more of our homeless LGBTQ+ community members who will benefit greatly from the protection it provides.”

About Wearsafe Labs

Wearsafe Labs, pioneers of personal protection products and communication services, is redefining the way people seek and provide help via its IoT platform and mobile app software. Based in Hartford, Connecticut, the Wearsafe platform provides consumers with comprehensive features including real-time tracking, live audio, voice activation, and more, all in a universal application. Wearsafe also has embedded Accident Medical Expense Insurance coverage from Zurich Insurance Company into every Wearsafe Tag at NO additional cost to the user, which provides medical expense coverage in the event a user experiences an accident and is ever injured. Wearsafe-enabled devices have been used in over 115 countries and provide more accurate data and context than any other personal safety technology. To learn more, visit wearsafe.com.

Share article on social media or email:

Crossroads Names Maite Uribe Vice President of Palliative Education


Maite Uribe is the new Vice President of Palliative Education at Crossroads Hospice & Palliative Care.

“Maite’s combined clinical and educational experience, as well as her passion for providing exceptional palliative care to patients and their families, will be a tremendous asset to our team,” said Crossroads CEO Perry Farmer. “We look forward to working together.”

Maite Uribe is the new Vice President of Palliative Education for Crossroads Hospice & Palliative Care, one of the nation’s leading end-of-life care providers. Uribe brings clinical, palliative care and educational experience to the newly created corporate Crossroads position.

As Vice President of Palliative Education, Uribe oversees the development, implementation and support of palliative care and hospice educational programs across 11 Crossroads locations in seven states.

“We are fortunate to have Maite join Crossroads,” said Dr. Timothy Ihrig, Chief Medical Officer. “Her wealth of experience, coupled with the highest level of clinical acumen is invaluable in supporting Crossroads’ mission. I look forward to working with and learning from Maite as we care for others,”

Before joining Crossroads, Uribe most recently served as a Palliative Care Nurse Practitioner for SA Health in Australia, the government health service for citizens of South Australia, where she cared for patients with advanced illness and provided end-of-life care.

During her time at SA Health, Uribe also expanded the health network’s palliative care capabilities with hospital-wide educational workshops and helped develop the network’s Last Days of Life Pathway, a systematic framework for clinicians to improve the end-of-life care experience for patients and their loved ones.

“Maite’s combined clinical and educational experience, as well as her passion for providing exceptional palliative care to patients and their families, will be a tremendous asset to our team,” said Crossroads CEO Perry Farmer. “We look forward to working together as we continue to advance and expand our delivery of palliative care.”

A graduate of Flinders University in Adelaide, Australia with a BS in Nursing and an MS in Palliative Care, Uribe is a member of the boards of the Laurel Hospice Foundation and Australasia Palliative Link International, and serves as an Executive Clinical Advisor to the General Practitioner Shared Care Program of South Australia.

Uribe said, “I am delighted to be part of the Crossroads team where there is such a long tradition of providing the right care at the right time as we constantly strive to elevate the care narrative.”

Crossroads Hospice & Palliative Care is committed to being at the forefront of the hospice and palliative care industries, continually shaping the way end-of-life care is viewed and administered. Crossroads’ mission is to provide highly unique, comprehensive, and compassionate hospice services to persons experiencing a life-limiting illness and to their caregivers. For more information, please visit http://www.crossroadshospice.com or contact Lisa Simon at lsimon@sprytecom.com or 215-545-4715 x22.

Share article on social media or email:

DecisionHealth announces 3 new home health virtual events for 2020.


We’ve seen the debut of a new case mix model while weathering a public health emergency, and now it’s time to ramp up for the annual ICD-10 coding updates.

DecisionHealth is excited to announce three unique virtual learning opportunities to provide home health professionals and coders with the latest coding, compliance, and payment training to ensure accurate reimbursement and prevent denials.

Home health agencies have been in the epicenter of the COVID-19 pandemic, experiencing new safety guidelines, infection control measures, increased scrutiny around patient care, and the launch of the Patient Driven Groupings Model (PDGM). With the latest ICD-10 codes set to be released on October 1 and new COVID-19 codes on the way, making sure your agency is compliant and has the proper documentation processes in place is more important than ever.

“The home health industry has experienced unprecedented change this year. We’ve seen the debut of a new case mix model while weathering a public health emergency, and now it’s time to ramp up for the annual ICD-10 coding updates. Keeping current with the latest education and best practices is essential for success in 2021 and beyond,” says Jan Milliman, HCS-D, Director for Association of Home Care Coding and Compliance (AHCC).

Our first virtual event is in just a few weeks, running October 13–15, focusing on the impact PDGM has had on home health agencies, how to properly use the new COVID-19 codes in response to the public health emergency, and gaining an understanding of the 2021 coding updates and guidelines. Perfect for coders of all levels, the expert speakers break down various practice scenarios to help debunk myths, avoid questionable encounter codes, and improve documentation. Learn more at https://events.simplifycompliance.com/event/coding-professionals-home-health-virtual-event/

The next virtual event is October 27-29, focusing on building a culture of compliance at your agency. This starts with establishing documentation best practices, policies, and procedures to prevent survey deficiencies and promote quality. Attendees will also get to hear from a panel of industry experts as they share real-life lessons learned to help agencies prepare for a visit from a surveyor or for conducting a compliance audit. Learn more at https://events.simplifycompliance.com/event/mastering-compliancehome-health-virtual-event/

The final virtual event is scheduled for November 2–3 and focuses on the revenue cycle processes that drive your agency’s billing and reimbursement. With a choppy first year of PDGM and COVID-19, the jobs of revenue cycle professionals, administrators, and executives are more difficult but more essential than ever. This 2-day event covers achieving accurate reimbursement under PDGM, strategies to streamline operations, and how to analyze your financial dashboards. Learn more at https://events.simplifycompliance.com/event/achieving-accurate-payment-home-health-virtual-event/

At DecisionHealth, we are committed to providing home health agencies with virtual events, continuing education, training, and more. For additional pricing, discount bundles, and additional information about upcoming events, please contact Customer Service at 1-855-225-5341, or e-mail customer@decisionhealth.com.

About DecisionHealth

For over 30 years, DecisionHealth has served as the industry’s leading source for home health agencies and specialty medical practices to receive the latest news, analysis, and regulatory guidance on Medicare coding and reimbursement, accreditation, benchmarks, payment, and HIPPA compliance. You also may know its flagship publications Part B News, Home Health Line, Medical Practice Compliance Alert, and Inside the Joint Commission, as well as its wide selection of coding books, educational events, and online tools like SelectCoder and Home Health Coding Center. Visit http://www.decisionhealth.com.

About AHCC

The Association of Home Care Coding & Compliance (AHCC) is a division of DecisionHealth, LLC, serving the staff-development needs of the home care industry through education, training, work tools, resources, community building/networking, and advocacy. AHCC offers professional certifications for coders and clinicians through the Board of Medical Specialty Coding & Compliance (BMSC), their credentialing arm. To learn more about membership and credentialing visit https://ahcc.decisionhealth.com.

Share article on social media or email:

VGXI Wins Best Contract Manufacturing Organization for the 2020 Vaccine Industry Excellence Awards


VGXI Vaccine Industry Excellence Awards

This award is a testament to the dedication of the entire VGXI team to delivering exceptional quality products and services, with the goal of ensuring both patient safety and clinical success for these next generation vaccines and therapies.

VGXI, Inc., a contract development and manufacturing organization specialized in production of pre-clinical through cGMP grade DNA-based biopharmaceuticals, announced it has been recognized as the winner for Best Contract Manufacturing Organization on September 30, 2020 at the Vaccine Industry Excellence (ViE) Awards. The ViE Awards are part of the annual World Vaccine Congress in Washington D.C., which was held virtually in 2020 due to the coronavirus pandemic. The awards are designed to highlight the efforts, positive contributions, and accomplishments of companies and individuals across the vaccine industry.

Finalists for the 12 highly competitive categories are determined though a rigorous process of industry nominations and shortlist voting over several months. The ViE Scientific Advisory Board oversees final judging and selection of winners.

“VGXI is honored to accept the award for Best CMO, and we want to reach out to all of our clients, partners, and collaborators in appreciation of their support,” stated VGXI COO Dorothy Peterson. “The award is a testament to the dedication of the entire VGXI team to delivering exceptional quality products and services, with the goal of ensuring both patient safety and clinical success for these next generation vaccines and therapies.”

Best CMO recognition comes as VGXI is in the process of establishing a new, expanded manufacturing facility to meet accelerating worldwide demand from the DNA vaccine, immunotherapy, and gene therapy industries. The new facility is targeted to be operational in early 2022 and will dramatically increase VGXI’s manufacturing capacity and flexibility for production of DNA and RNA products.

ABOUT VGXI, INC.

VGXI, Inc. is a leading provider of manufacturing and development services for DNA vaccines and gene therapies. The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. VGXI, Inc. is a wholly-owned subsidiary CDMO of GeneOne Life Science, Inc. To learn more or request a quote, visit https://www.vgxii.com.

ABOUT GENEONE LIFE SCIENCE

GeneOne Life Science Inc. (“GeneOne” KOSPI: 011000) is an international DNA vaccine and product developer, and leading contract manufacturer of DNA plasmid-based agents for pre-clinical and clinical trials for global companies and institutions. It researches and develops DNA vaccines and products to prevent and treat incurable diseases in South Korea and internationally. The company is headquartered in Seoul, South Korea. VGXI, Inc., GeneOne’s wholly-owned manufacturing subsidiary located in Texas, is the largest pure-play cGMP DNA plasmid manufacturing facility in the world. For more information, visit https://www.genels.com.

CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS

Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

Share article on social media or email:

Innovations in Patient Experience Explored by The Beryl Institute


News Image

Reinforcing its commitment to elevate the human experience in healthcare, The Beryl Institute publishes a new white paper, Innovation Awards 2020: Celebrating Creativity and Ingenuity in Improving Patient Experience.

Reinforcing its commitment to elevate the human experience in healthcare, The Beryl Institute publishes a new white paper, Innovation Awards 2020: Celebrating Creativity and Ingenuity in Improving Patient Experience. The white paper recognizes three institutions as award recipients selected from submissions to the Institute’s second annual Patient Experience Innovation Award program. The awards provide a platform for sharing and celebrating new ideas from across the globe to improve patient experience.

With discoveries and opportunities transferrable to many healthcare settings, the paper also shares other innovative submissions explored through The Beryl Institute’s Experience Framework. This includes eight strategic lenses through which organizations can address experience improvement and excellence.

Listed in the order of highest submission volume by Innovation Award applicants, the eight lenses are:

  • Patient, Family, and Community Engagement
  • Staff and Provider Engagement
  • Culture & Leadership
  • Innovation & Technology
  • Quality & Clinical Excellence
  • Environment & Hospitality
  • Infrastructure & Governance
  • Policy & Measurement


“When we create and hold the space for innovation to happen, to make the suggestion of change ok, we build cultures and environments of care that will work to consistently find new possibilities, to question with respect, to stretch with purpose and to look forward with hope,” said Jason A. Wolf, Ph.D., CPXP, President & CEO of The Beryl Institute. “The winners of the 2020 Innovation Awards and all the participants in the award process help us see that if we are true to those ideas, great things are possible. There is much to learn on what they helped change and much we can all apply in moving forward.”

To access this white paper, visit: https://www.theberylinstitute.org/store/viewproduct.aspx?id=17171541

###

About The Beryl Institute

The Beryl Institute is the global community of practice committed to elevating the human experience in healthcare. We believe human experience is grounded in experiences of patients & families, those who work in healthcare and the communities they serve. We define patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care.

Share article on social media or email:

TrialScope Adds Eisai to Its Community of Study Sponsors


TrialScope, the global leader in clinical trial disclosure and transparency management technology, has added a new study sponsor to its growing customer roster. Eisai Inc. will manage its global clinical trial disclosure compliance process for upwards of 800 studies using the TrialScope Disclose™ platform.

TrialScope customers include 16 of the top 20 industry sponsors, who rely on its technology for trial disclosure management, patient engagement and study recruitment. Collectively, TrialScope customers are responsible for more than 40 percent of all industry trials on ClinicalTrials.gov and the EU-CTR.

With clinical trials conducted worldwide, Eisai will take advantage of TrialScope’s Global Registry Compliance module, enabling its Global Clinical Trial Transparency department to stay on top of evolving global regulations. The module’s rules engine tracks and updates over 65 regulations for more than 35 clinical trial registries across 100-plus countries.

TrialScope Disclose functionality includes field-level commenting and review-and-approval workflow functionality. These features, ensuring timely compliance and audit-readiness, will facilitate global collaboration for Eisai’s Global Clinical Trial Transparency department.

“Clinical trial disclosure regulatory compliance is important to Eisai, and not just because it is mandated legally,” said Neil Yolland, Director, Global Clinical Trial Transparency and Clinical & Business Systems at Eisai. “Clinical trial transparency reflects our corporate philosophy of ‘hhc’ – human health care – viewing everything from the perspective of patients and their families. We disclose trial information because it is the right thing to do, and we are ready to streamline the process with the TrialScope Transparency Cloud.”

“We welcome Eisai to the TrialScope community and admire its commitment to global clinical trial disclosure and transparency,” said TrialScope CEO Jeff Kozloff. “We are eager to help Eisai realize the many efficiencies of our platform in terms of automation and trial data reuse.”

For more information on TrialScope or TrialScope Disclose, visit TrialScope.com.

About TrialScope

TrialScope gives your clinical trial data superpowers™. The TrialScope Transparency Cloud™ makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit TrialScope.com.

About Eisai Inc.

At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.

Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more, visit https://us.eisai.com/ and follow us on Twitter and LinkedIn.

Share article on social media or email: